FinancialBuzz.com News Commentary NEW YORK, October 2, 2018 /PRNewswire/ -- According to a report from New Frontier Data, the U.S. legal cannabis market is expected to grow at a compound annual growth rate (CAGR) of 14.7% to USD 25 Billion by 2025. The market can be segmented into medical cannabis and recreational cannabis and the demand for medical cannabis continues to increase. The report projects that the medical market is set to grow from USD 5.1 Billion in 2017 to USD 12.5 Billion by 2025, with a GAGR of 11.8%, while the recreational market is projected to grow at a faster rate of 18.4% during the forecast period. The recreational market is also expected to have a value of USD 12.5 Billion by 2025. Giadha Aguirre De Carcer, New Frontier Data CEO and Founder explains, "Across the globe, we have seen massive expansion as more than 50 countries are legalizing or decriminalizing cannabis. However, the United States continues to lead the way in cannabis consumption in legal medical and adult use markets." Koios Beverage Corp. (OTC: KBEVF), New Age Beverages Corporation (NASDAQ: NBEV), Level Brands, Inc. (NYSE: LEVB), Emblem Corp. (NASDAQ: EMMBF), VIVO Cannabis Inc. (OTC: VVCIF) Cannabis product categories are becoming more diverse. In a report by Bloomberg Erik Knutson, founder and CEO of cannabis-infused drink manufacturer, Keef Brands, explained, "I think eventually the drinks sector will be the largest edibles sector... People don't get together and eat slices of a brownie. It's not social. Sipping on drinks is what we know--you get together and you drink." In 2018, soda sales have hit a 30-year low as consumers flee for healthier drinks, according to Bloomberg. Koios Beverage Corp. (OTC: KBEVF) is also listed on the Canadian Stock Exchange under (CSE: KBEV). Earlier last week, the Company announced that it has, "the world's first cannabis infused nootropic beverage is scheduled for release in November. The new product will be a collaboration with the Company's partner Keef Brands, a division of CanCore Concepts Inc. (CanCore), and Koios' wholly owned subsidiary Cannavated Beverage Corp. Cannavated was formed specifically to license the nootropic formulas to other companies working in the area of cannabis-infused beverages. Keef Brands will manufacture, market and sell a line of beverages that are not only infused with THC, but also contain the nootropic supplements from the Koios line of brain enhancing functional beverages. The resulting product will be the first in the world to combine cannabis infusion with nootropic supplements that enhance the consumer's mental acuity. Keef Brands has the exclusive rights to the Cannavated nootropic formula for Colorado, with the option of expanding the licensing agreement throughout the U.S., provided it complies with all rules and regulations in the markets where cannabis has been made legal. 'We first announced this joint development project in early September, and we're very pleased to be able to announce this ground-breaking cannabis beverage will be available in Colorado in November,' said Koios Chief Executive Officer Chris Miller. 'This is also the first product we are releasing through our partnership with Keef Brands, one of the world leaders in the cannabis beverage industry.' Gross profits from sales - after calculating the overall Cost of Goods Sold (COGS) - will be split evenly between Cannavated and Keef Brands. The non-carbonated cannabis beverage will be high in cannabidiol - better known as CBD - but will also contain THC, which is the psychoactive ingredient in the cannabis plant. This initial product will contain four parts CBD to one part THC, with 20 milligrams of THC in a 12-ounce can. Cannavated was formed as a separate company that licenses its proprietary nootropic formulations to companies that independently research and produce cannabis-infused beverages. Keef Brands, through its network of licensed manufacturing partners, is among the world's largest producers and distributors of cannabis beverages, and is the leading producer in Colorado by volume, where both companies are located. 'This partnership allows us to introduce a very exciting and very unique product to the cannabis market,' said Keef Brands Chief Operating Officer Travis Tharp. 'Cannavated is a market leader in the area of mind-enhancing, nootropic beverages, and we feel combining our areas of expertise has allowed us to provide our customers and distributors with a product no other producer can currently match.' Initial distribution of the new cannabis beverage will be limited to the State of Colorado, but will expand to other jurisdictions in the US once the two companies can be assured production will meet demand." New Age Beverages Corporation (NASDAQ: NBEV) is a Colorado-based healthy functional beverage company that was created over the past two years with the combination of B?cha Live Kombucha(R), XingTea(R), Coco-Libre(R), and Marley(R), to create a one-stop-shop solution for retailers and distributors providing healthier beverages in the disruptive growth segments of the USD 1 Trillion non-alcoholic beverage industry. New Age Beverages Corporation recently announced that it intends to debut its portfolio of CBD infused beverages at the upcoming North American Convenience Store show (NACS) to be held at the Las Vegas Convention Center on October 7-10th, 2018. Zach Ross, Marley Marketing Manager at New Age commented, "We believe we have developed unique consumer insights and accessed superior technology in CBD-infused beverages over the past year, and we are excited to share those insights with key retail partners. We believe we are in a position to bring national leadership to this emerging growth segment, and intend to launch the most efficacious and safe CBD-infused products for consumers, with the most responsible marketing and education to a segment that has potential to be transformative to healthy functional beverages." Level Brands, Inc. (NYSE: LEVB) is an innovative marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses. Level Brands, Inc. recently announced, through its licensing agreement with Isodiol International, Inc., the online launch of five new cannabidiol (CBD) products under the kathy ireland(R) Health & Wellness brand. "It's very exciting to be at the forefront of the CBD industry, as we educate families about the power of CBD without THC," states Kathy Ireland, Chairman Emeritus and Chief Brand Strategist of Level Brands. "We continue to believe that the CBD industry will see enormous growth over the next decade on a global scale. Recently, the Brightfield Group reported that the global market for CBD could top USD 22 Billion in the next four years. If passed, the 2018 Farm Bill which includes the Hemp Farming Act of 2018, will remove hemp as a designated controlled substance thereby legalizing the crop under federal law, which will allow CBD to be legally sold in all 50 states. The passage of the 2018 Farm Bill, which would replace the 2017 Farm Bill which expires on September 30th, 2018, would be a significant positive development for the industry." Emblem Corp. (NASDAQ: EMMBF), through its wholly-owned subsidiary Emblem Cannabis Corporation, is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Emblem Corp. and GreenSpace Brands recently announced a strategic partnership to develop and commercialize cannabidiol ("CBD"
$NBEV: Research Projects the U.S. Medical Cannabis Market
FinancialBuzz.com News Commentary NEW YORK, October 2, 2018 /PRNewswire/ -- According to a report from New Frontier Data, the U.S. legal cannabis market is expected to grow at a compound annual growth rate (CAGR) of 14.7% to USD 25 Billion by 2025. The market can be segmented into medical cannabis and recreational cannabis and the demand for medical cannabis continues to increase. The report projects that the medical market is set to grow from USD 5.1 Billion in 2017 to USD 12.5 Billion by 2025, with a GAGR of 11.8%, while the recreational market is projected to grow at a faster rate of 18.4% during the forecast period. The recreational market is also expected to have a value of USD 12.5 Billion by 2025. Giadha Aguirre De Carcer, New Frontier Data CEO and Founder explains, "Across the globe, we have seen massive expansion as more than 50 countries are legalizing or decriminalizing cannabis. However, the United States continues to lead the way in cannabis consumption in legal medical and adult use markets." Koios Beverage Corp. (OTC: KBEVF), New Age Beverages Corporation (NASDAQ: NBEV), Level Brands, Inc. (NYSE: LEVB), Emblem Corp. (NASDAQ: EMMBF), VIVO Cannabis Inc. (OTC: VVCIF) Cannabis product categories are becoming more diverse. In a report by Bloomberg Erik Knutson, founder and CEO of cannabis-infused drink manufacturer, Keef Brands, explained, "I think eventually the drinks sector will be the largest edibles sector... People don't get together and eat slices of a brownie. It's not social. Sipping on drinks is what we know--you get together and you drink." In 2018, soda sales have hit a 30-year low as consumers flee for healthier drinks, according to Bloomberg. Koios Beverage Corp. (OTC: KBEVF) is also listed on the Canadian Stock Exchange under (CSE: KBEV). Earlier last week, the Company announced that it has, "the world's first cannabis infused nootropic beverage is scheduled for release in November. The new product will be a collaboration with the Company's partner Keef Brands, a division of CanCore Concepts Inc. (CanCore), and Koios' wholly owned subsidiary Cannavated Beverage Corp. Cannavated was formed specifically to license the nootropic formulas to other companies working in the area of cannabis-infused beverages. Keef Brands will manufacture, market and sell a line of beverages that are not only infused with THC, but also contain the nootropic supplements from the Koios line of brain enhancing functional beverages. The resulting product will be the first in the world to combine cannabis infusion with nootropic supplements that enhance the consumer's mental acuity. Keef Brands has the exclusive rights to the Cannavated nootropic formula for Colorado, with the option of expanding the licensing agreement throughout the U.S., provided it complies with all rules and regulations in the markets where cannabis has been made legal. 'We first announced this joint development project in early September, and we're very pleased to be able to announce this ground-breaking cannabis beverage will be available in Colorado in November,' said Koios Chief Executive Officer Chris Miller. 'This is also the first product we are releasing through our partnership with Keef Brands, one of the world leaders in the cannabis beverage industry.' Gross profits from sales - after calculating the overall Cost of Goods Sold (COGS) - will be split evenly between Cannavated and Keef Brands. The non-carbonated cannabis beverage will be high in cannabidiol - better known as CBD - but will also contain THC, which is the psychoactive ingredient in the cannabis plant. This initial product will contain four parts CBD to one part THC, with 20 milligrams of THC in a 12-ounce can. Cannavated was formed as a separate company that licenses its proprietary nootropic formulations to companies that independently research and produce cannabis-infused beverages. Keef Brands, through its network of licensed manufacturing partners, is among the world's largest producers and distributors of cannabis beverages, and is the leading producer in Colorado by volume, where both companies are located. 'This partnership allows us to introduce a very exciting and very unique product to the cannabis market,' said Keef Brands Chief Operating Officer Travis Tharp. 'Cannavated is a market leader in the area of mind-enhancing, nootropic beverages, and we feel combining our areas of expertise has allowed us to provide our customers and distributors with a product no other producer can currently match.' Initial distribution of the new cannabis beverage will be limited to the State of Colorado, but will expand to other jurisdictions in the US once the two companies can be assured production will meet demand." New Age Beverages Corporation (NASDAQ: NBEV) is a Colorado-based healthy functional beverage company that was created over the past two years with the combination of B?cha Live Kombucha(R), XingTea(R), Coco-Libre(R), and Marley(R), to create a one-stop-shop solution for retailers and distributors providing healthier beverages in the disruptive growth segments of the USD 1 Trillion non-alcoholic beverage industry. New Age Beverages Corporation recently announced that it intends to debut its portfolio of CBD infused beverages at the upcoming North American Convenience Store show (NACS) to be held at the Las Vegas Convention Center on October 7-10th, 2018. Zach Ross, Marley Marketing Manager at New Age commented, "We believe we have developed unique consumer insights and accessed superior technology in CBD-infused beverages over the past year, and we are excited to share those insights with key retail partners. We believe we are in a position to bring national leadership to this emerging growth segment, and intend to launch the most efficacious and safe CBD-infused products for consumers, with the most responsible marketing and education to a segment that has potential to be transformative to healthy functional beverages." Level Brands, Inc. (NYSE: LEVB) is an innovative marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses. Level Brands, Inc. recently announced, through its licensing agreement with Isodiol International, Inc., the online launch of five new cannabidiol (CBD) products under the kathy ireland(R) Health & Wellness brand. "It's very exciting to be at the forefront of the CBD industry, as we educate families about the power of CBD without THC," states Kathy Ireland, Chairman Emeritus and Chief Brand Strategist of Level Brands. "We continue to believe that the CBD industry will see enormous growth over the next decade on a global scale. Recently, the Brightfield Group reported that the global market for CBD could top USD 22 Billion in the next four years. If passed, the 2018 Farm Bill which includes the Hemp Farming Act of 2018, will remove hemp as a designated controlled substance thereby legalizing the crop under federal law, which will allow CBD to be legally sold in all 50 states. The passage of the 2018 Farm Bill, which would replace the 2017 Farm Bill which expires on September 30th, 2018, would be a significant positive development for the industry." Emblem Corp. (NASDAQ: EMMBF), through its wholly-owned subsidiary Emblem Cannabis Corporation, is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Emblem Corp. and GreenSpace Brands recently announced a strategic partnership to develop and commercialize cannabidiol ("CBD"
Top 10 Most Recent News Articles
What to Expect: Your First Therapy Session Insights
Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...
Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
Quest Diagnostics Faces Class Action After Data Breach
Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...
Continue Reading
Millrose Faces Securities Fraud Suit Amidst Decline
Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...
Continue Reading
John Wong's Decade as Estate Planning Specialist
One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...
Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans
NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...
Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause
SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...
Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle
Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...
Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment
Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....
Continue Reading
Tony Perkins' Church Tour amid Controversial Vote
Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...
Continue ReadingTop 5 Most Recently Viewed Articles
Banco Santander to Redeem €187.6 Million CoCos Efficiently
Banco Santander Approaches €187.6 Million CoCos Redemption BANCO SANTANDER S.A. has made a significant announcement regarding the redemption of its contingent convertible securities (CoCos). This decision, which is seen as a strategic move, highlights the bank's commitment to financial efficacy and investor satisfaction. Additionally, the redemption covers a total...
Continue Reading
Revolutionizing ADC Characterization with Biozen Native Columns
Transforming Biotherapeutic Characterization First of its Kind in Biotherapeutic Antibody Characterization Phenomenex Inc., a leader in separation science technology, has launched Biozen Native RP-1 and RP-5 chromatography columns. These innovative products are engineered to meet the growing demand for effective characterization methods for Antibody-Drug Conjugates...
Continue Reading
TG Therapeutics to Attend the Upcoming Global Healthcare Event
Participation in Global Healthcare Conference TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves as it prepares to take part in a prestigious healthcare event. Michael S. Weiss, the Chairman and CEO of the company, is scheduled to speak during the fireside chat at the Goldman Sachs Annual Global Healthcare Conference. This significant event will be hosted in Miami and...
Continue Reading
Ogury One: Revolutionizing Advertising in a Privacy-Centric World
Ogury One: A New Era in Digital Advertising Ogury has launched its new client-facing platform, Ogury One, designed to revolutionize the way brands and agencies manage their advertising campaigns. As a leader in privacy-centric advertising solutions, Ogury One provides users with a comprehensive suite that facilitates seamless audience planning, activation, and reporting....
Continue Reading
Exploring Top Energy Stocks Benefiting from Industry Shifts
Understanding the Shift in Energy Supply Dynamics The global energy landscape is undergoing significant changes, particularly as liquefied natural gas (LNG) supply anticipated an increase. Analysts believe that the next few years will see substantial growth in LNG, especially in response to evolving demand and new technologies. As the market adjusts, smart investors are...
Continue Reading